ObjectiveTo discuss the clinical characteristics, treatment and prevention of abdominal wall endometriosis (AWE). MethodsA retrospective analysis of 295 cases of AWE from February 2007 to August 2011 in our hospital was performed. ResultsAll of the patients had abdominal operations before and 99% of them had a history of caesarean section. The mean age of the patients was (31.55±4.52) years old. The average size of the mass was (2.66±1.12) cm, significantly larger than the estimation of ultrasonography before operation which was (1.91±0.83) cm (P<0.001). No relapse was discovered five months to three years after the operation. ConclusionIt is easy to diagnose abdominal wall endometriosis through medical history, clinical characteristics, physical signs and ultrasonic assessment. The prevention of AWE is very important. Operation is still the best treatment for AWE.
目的：探讨腹腔镜下卵巢子宫内膜异位囊肿保守手术的疗效。方法:2005年1月至2006年7月间采用腹腔镜保守手术治疗卵巢子宫内膜异位囊肿患者106例。患者平均年龄（32.5±6.4）岁，平均病程2.1年。合并不孕症21例，痛经54例，性交痛38例，慢性盆腔痛76例。无明显自觉症状仅以普查发现附件肿物者23例。结果：106例患者中行囊肿剔除术100例（94.3％），其中单侧卵巢内膜异位囊肿剔除61例，双侧卵巢内膜异位囊肿剔除39例（其中双侧囊肿剔除术34例，一侧囊肿剔除而另一侧附件切除5例），单侧附件切除6例。所有患者平均手术时间(38±11)分钟，平均出血量（35.6±12.5）mL。首次排气时间平均在术后（22.3±4.2）小时。平均住院天数（4.2±1.3）天。随访3～18个月，除21例不孕患者均于术后服用内美通或孕三烯酮2.5 mg 2次/周共3～6个月。106例患者中治疗性交痛总有效率92.2％，治疗慢性盆腔痛总有效率92.1％，治疗痛经总有效率90.7％。21例不孕患者中总妊娠率61.9％，7例(53.8％)半年内妊娠，6例（46.2％）1年内妊娠。术后复发9例（8.5％）。结论:对保留生育功能的卵巢子宫内膜异位囊肿患者，腹腔镜下保守手术是目前公认的安全、有效的手术方法。
①关于药物引起的卵巢抑制:1篇系统评价发现,使用卵巢抑制药治疗子宫内膜异位症与安慰剂或达那唑相比,妊娠率无明显差异.该评价还发现,卵巢抑制药引起的不良反应包括体重增加、潮热和骨质疏松症,达那唑可能引起剂量相关的体重增加和雄激素样作用. ②宫腔内人工授精+促性腺激素:1个RCT发现,宫腔内人工授精+促性腺激素治疗与不治疗相比,可明显提高活产率.第2个RCT发现,期待疗法与宫腔内人工授精+垂体降调节+促性腺激素治疗后的分娩率无明显差异.第3个RCT发现,宫腔内人工授精+促性腺激素治疗与单用宫腔内人工授精相比,仅明显提高妊娠率. ③体外受精:我们没有找到关于子宫内膜异位症引起不孕妇女接受受精体外治疗的RCT. ④手术治疗:两个比较腹腔镜手术与诊断性腹腔镜的RCT发现,在妊娠率和活产率方面结论不一.
ObjectiveTo evaluate the mid-term clinical and radiological results of dynamic cervical implant (DCI) arthroplasty for degenerative cervical disc disease in Chinese population.MethodsBetween April 2010 and June 2011, 25 patients with single-segmental degenerative cervical disc disease underwent DCI replacement. Visual Analogue Scale (VAS), Japanese Orthopaedic Association (JOA) scores, Neck Disability Index (NDI) and 36-Item Short Form Health Survey Questionnaires (SF-36) were used for evaluation of neurological function and pain severity, before and after operation, and during follow-up period. Radiographic evaluation included range of motion (ROM) of C2–7, surgical segments and adjacent level, intervertebral height of the surgical segments, migration, subsidence of the implant and heterotopic ossification (HO).ResultsThe mean follow-up period was 72.3 months (ranged from 68 to 78 months). The VAS, JOA, NDI, and SF-36 mental and physical component summaries improved significantly after surgery (P<0.05) and remained stable over the whole observation period. The ROM (flexion/extension) and intervertebral height at the level treated with DCI remained at the first 2 years and partly reduced at the final follow-up. ROM for C2–7 and adjacent levels maintained during the follow-up period. DCI subsidence was observed in 11 segements, and 9 segements appeared heterotopic ossification.ConclusionsClinical efficacy of DCI arthroplasty improves and maintaines during the mid-to-long period of follow-up. HO formation is a common phenomenon, leading a dramatic decrease of ROM at index level and recurrence of neurological symptoms. Rate of implant subsidence and migration is relatively high, leaving a potential risk of symptom at index level and adjacent segment degeneration. It suggests that for patients with degenerative cervical disc disease, total disc replacement or anterior cervical discectomy and fusion is still the first choice instead of DCI arthroplasty.
目的:探讨米非司酮治疗异位妊娠的疗效,安全性及对患者生育的影响。方法:选取符合保守治疗条件患者31例,观察米非司酮治疗异位妊娠过程中的临床症状,各项试验室指标的变化;出现不良反应的几率及严重程度;治疗后输卵管的通畅情况,以判断是否对患者生育造成影响。结果:治疗成功率为87.09%;不良反应出现率为19.35%,均为轻度不适;成功病例中未育患者输卵管通畅率为100%。结论:米非司酮是一种治疗异位妊娠的高效药物,具有安全性高,不良反应少,对生育无影响的优点。
ObjectiveThe purpose of this study was to better delineate the clinical spectrum of periventricular nodular heterotopia (PNH) in a large patient population to better understand social support in people with PNH and epilepsy in west China. Specifically, this study aimed to relate PNH subtypes to clinical or epileptic outcomes and epileptic discharges by analyzing anatomical features. MethodsThe study included 70 patients with radiologically confirmed nodular heterotopias and epilepsy. We also recruited healthy controls from nearby urban and rural areas. People with PNH and epilepsy and healthy controls were gender-and age-matched. Two-sided Chi-square test and Fisher's exact t-test were used to assess associations between the distribution of PNHs and specific clinical features. ResultsBased on imaging data, patients were subdivided into three groups: (a) classical (bilateral frontal and body, n=25), (b) bilateral asymmetrical or posterior (n=9) and (c) unilateral heterotopia (n=36). Most patients with classical heterotopia were females, but were mostly seizure-free. Patients with unilateral heterotopia were prone to develop refractory epilepsy. ConclusionsEach group's distinctive genetic mutations, epileptic discharge patterns and overall clinical outcomes confirm that the proposed classification system is reliable. These findings could not only be an indicator of a more severe morphological and clinical phenotype, but could also have clinical implications with respect to the epilepsy management and optimization of therapeutic options.